Leidos director awarded shares and new stock option

Leidos Holdings director Robert S. Shapard reported new equity awards.

Rhea-AI Filing Summary

Leidos Holdings director Robert S. Shapard reported new equity awards. He received 1,067 shares of common stock as a grant or award, bringing his directly held common stock to 60,027.08 shares. He also received a stock option for 1,281 shares at an exercise price of $131.26 per share.

The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting, and expires on May 7, 2033. In addition, he reports 2,500 shares held indirectly through a family limited partnership and 1,624.9954 shares held indirectly through a Key Executive Stock Deferral Plan. The filing shows acquisitions via compensation grants rather than open-market buying or selling.

Insider Trade Summary

Grant/Award: 2,348 shares

Grant/Award 4 txns

Insider SHAPARD ROBERT S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	$0.00
Grant/Award	Common Stock	1,067	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 contracts (Direct); Common Stock — 60,027.08 shares (Direct); Common Stock — 1,624.9954 shares (Indirect, by Key Executive Stock Deferral Plan); Common Stock — 2,500 shares (Indirect, By Family Limited Partnership)

Footnotes (1)

1. F1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Key Figures

Stock grant: 1,067 shares Direct holdings after grant: 60,027.08 shares Stock option size: 1,281 shares +4 more

7 metrics

Stock grant 1,067 shares Common stock grant to director on May 8, 2026

Direct holdings after grant 60,027.08 shares Common stock directly held after award

Stock option size 1,281 shares Underlying Leidos common stock for new option

Option exercise price $131.26 per share Conversion or exercise price of stock option

Option expiration May 7, 2033 Expiration date of stock option award

Indirect family LP holdings 2,500 shares Common stock held by Family Limited Partnership

Indirect deferral plan holdings 1,624.9954 shares Common stock held by Key Executive Stock Deferral Plan

Key Terms

Stock Option (Right to Buy), Key Executive Stock Deferral Plan, Family Limited Partnership, Grant, award, or other acquisition, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" for 1,281.0000 shares"

Key Executive Stock Deferral Plan financial

"nature_of_ownership: "by Key Executive Stock Deferral Plan""

Family Limited Partnership financial

"nature_of_ownership: "By Family Limited Partnership""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

vest and become exercisable financial

"The option shall vest and become exercisable in full on the earlier of..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leidos (LDOS) director Robert S. Shapard acquire in this Form 4?

Robert S. Shapard received 1,067 shares of Leidos common stock as a grant and a stock option for 1,281 shares. These awards represent compensation rather than open-market purchases or sales, increasing his equity-based exposure to Leidos Holdings.

What are the terms of Robert S. Shapard’s new Leidos stock option?

The stock option covers 1,281 Leidos common shares at an exercise price of $131.26 per share. It vests in full on the earlier of one year from the grant date or the next annual stockholder meeting’s conclusion and expires on May 7, 2033.

How many Leidos common shares does Robert S. Shapard hold directly after this filing?

After the reported equity grant, Robert S. Shapard directly holds 60,027.08 shares of Leidos common stock. This total reflects his position following the 1,067-share award reported as a grant or other acquisition in the Form 4 filing.

What indirect Leidos holdings are reported for Robert S. Shapard?

The filing lists 2,500 Leidos common shares held indirectly through a family limited partnership and 1,624.9954 shares held indirectly through a Key Executive Stock Deferral Plan. These positions are reported as indirect ownership interests associated with Robert S. Shapard.

Does this Leidos Form 4 show any open-market buying or selling by Robert S. Shapard?

The Form 4 shows compensation-related grants, not open-market trades. It reports an award of 1,067 common shares and a stock option for 1,281 shares, with no transactions coded as open-market purchases or sales in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 08:54 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHAPARD ROBERT S

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,067	A	$0	60,027.08	D
Common Stock								1,624.9954	I	by Key Executive Stock Deferral Plan
Common Stock								2,500	I	By Family Limited Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027(1)	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of Robert S. Shapard	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)